Register entry
Cambrex Karlskoga AB
- Registered sites
- 1
- Drug products
- 13
- Live patents
- 0
- Countries
- 1
- Base
- Sweden
Authorisation
Registered operations
What the FDA has registered these sites to do. This is the regulatory record, not a marketing claim.
Analytical testingActive ingredient (API) manufacture
Sites
Facilities
1| Site | Location | Operations | FEI |
|---|---|---|---|
| Cambrex Karlskoga AB | KarlskogaSweden | Analytical testing, Active ingredient (API) manufacture | 3001686607 |
Catalogue
Marketed products
13Showing 13 of 13.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| - | 4-Amiinobenzoic acid | POWDER | BULK INGREDIENT |
| - | BUPIVACAINE HYDROCHLORIDE | POWDER | BULK INGREDIENT |
| - | Benzoyl peroxide, hydrous | POWDER | BULK INGREDIENT |
| - | Berotralstat Dihydrochloride | POWDER | BULK INGREDIENT |
| - | Bupivacaine base | POWDER | BULK INGREDIENT |
| - | LIDOCAINE | POWDER | BULK INGREDIENT |
| - | Lidocaine hydrochloride | POWDER | BULK INGREDIENT |
| - | Mesalamine | POWDER | BULK INGREDIENT |
| - | Momelotinib dihydrochloride monohydrate | POWDER | BULK INGREDIENT |
| - | Olanzapine | POWDER | BULK INGREDIENT |
| - | RIVASTIGMINE | POWDER | BULK INGREDIENT |
| - | Tesofensine/NS2330 citrate | POWDER | BULK INGREDIENT |
| - | Zongertinib | POWDER | BULK INGREDIENT |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.